
Discover Viatris
Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA

Discover Viatris
Viatris and Ocuphire Pharma Announce U.S. FDA Approval of New Eye Care Treatment for Drug-Induced Mydriasis

Patient Inspiration
In Navigating Cancer, Leah Evert Finds Permission to Discover Joy

Patient Inspiration
Proactive Steps Help Barrett Jeffers Defy a Family History of Heart Disease

Discover Viatris